Salvage use of allogeneic HSCT after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the EBMT Chronic Malignancies Working Party.
Fiche publication
Date publication
avril 2017
Journal
Haematologica
Auteurs
Membres identifiés du Cancéropôle Est :
Dr LIOURE Bruno
Tous les auteurs :
Sobh M, Michallet M, Dubois V, Iacobelli S, Koster L, Van Biezen A, Fegueux N, Tabrizi R, Finke J, El-Cheikh J, Schipperus M, Meijer E, von dem Borne P, Petersen E, Russell N, Tholouli E, Passweg J, Garban FR, Maertens J, Chevalier P, Maillard N, Volin L, Francois S, Lioure B, Beguin Y, Gluckman E, Ruggeri A, Garderet L, Kröger N
Lien Pubmed
Mots clés
Adult, Female, Graft vs Host Disease, etiology, Hematopoietic Stem Cell Transplantation, methods, Humans, Male, Middle Aged, Multiple Myeloma, diagnosis, Neoplasm Recurrence, Local, Survival Analysis, Transplantation Conditioning, methods, Transplantation, Homologous, Treatment Outcome, Unrelated Donors, Young Adult
Référence
Haematologica. 2017 Apr;: